Myosin Therapeutics

Myosin Therapeutics is a biotechnology company focused on developing therapies for central nervous system and oncology indications, providing a targeted platform for molecular nano-motor proteins. The company’s lead programs for glioblastoma and stimulants utilize barrier-targeting myosin motor proteins, which play critical roles in a wide range of cellular processes.